INVESTABOT
Equity Research
XNAS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
TL;DR: Bio-Techne Corporation disclosed an officer change on September 14, 2026, in the context of its pending merger with Merck KGaA, Darmstadt, Germany.
Bio-Techne (TECH) had 1 Form 144 pre-sale notice filed on 2026-05-08. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
open-market Form 4 only - grants, exercises, tax withholding excluded
0 buyers - 0 unique sellers · 10 accumulating - 3 trimming - 0 unchanged
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| September 28, 2026 | Higgins John L | — | OPTION_EXERCISE | -15,940 | — | — |
| September 28, 2026 | Higgins John L | — | TAX_WITHHOLD | -5,562 | $73 | ~$0.4M |
| September 28, 2026 | Higgins John L | — | OPTION_EXERCISE | 15,940 | — | — |
| September 22, 2026 | Baumgartner Robert V | — | OPTION_EXERCISE | -15,940 | — | — |
| September 22, 2026 | Baumgartner Robert V | — | TAX_WITHHOLD | -5,559 | $73 | ~$0.4M |
| September 22, 2026 | Baumgartner Robert V | — | OPTION_EXERCISE | 15,940 | — | — |
| August 17, 2026 | Bohnen Shane | SVP - General Counsel | GRANT | 11,344 | — | — |
| August 17, 2026 | Bohnen Shane | SVP - General Counsel | GRANT | 18,432 | — | — |
| August 17, 2026 | Kelderman Kim | Chief Executive Officer | GRANT | 57,590 | — | — |
| August 17, 2026 | Kelderman Kim | Chief Executive Officer | GRANT | 93,582 | — | — |
| August 17, 2026 | Hippel James | CFO | GRANT | 22,438 | — | — |
| August 17, 2026 | Hippel James | CFO | GRANT | 36,459 | — | — |
| August 17, 2026 | Herr Amy E. | — | GRANT | 1,381 | — | — |
| August 17, 2026 | Geist William | PRESIDENT, PROTEIN SCIENCES | GRANT | 14,762 | — | — |
| August 17, 2026 | Geist William | PRESIDENT, PROTEIN SCIENCES | GRANT | 23,985 | — | — |
| August 17, 2026 | Crouse Steven C. | President - Diag & Spatial Bi | GRANT | 8,702 | — | — |
| August 17, 2026 | Crouse Steven C. | President - Diag & Spatial Bi | GRANT | 14,140 | — | — |
| August 15, 2026 | Kelderman Kim | Chief Executive Officer | OPTION_EXERCISE | 21,470 | — | — |
| August 15, 2026 | Kelderman Kim | Chief Executive Officer | TAX_WITHHOLD | -10,821 | $72 | ~$0.8M |
| August 15, 2026 | Kelderman Kim | Chief Executive Officer | OPTION_EXERCISE | -554 | — | — |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| May 8, 2026 | Joshua Molho | — | 6,636 | SEC |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| BlackRock | 14,987,870 | ~$1.1B | — | August 13, 2024 |
| Vanguard Group | 17,810,878 | ~$1.0B | — | January 29, 2026 |
| BlackRock | 14,025,816 | ~$990.9M | 14.4% | August 7, 2026 |
| Fidelity (FMR) | 12,794,784 | ~$904.0M | 62.0% | August 13, 2026 |
| BlackRock | 12,129,125 | ~$713.3M | — | February 12, 2026 |
| BlackRock | 12,264,513 | ~$640.9M | 1.1% | May 13, 2026 |
| Goldman Sachs | 7,343,324 | ~$518.8M | 277.8% | August 14, 2026 |
| Morgan Stanley | 8,345,414 | ~$490.8M | — | May 27, 2026 |
| Morgan Stanley | 6,374,717 | ~$450.4M | -25.3% | August 13, 2026 |
| Morgan Stanley | 8,532,873 | ~$445.9M | 2.3% | May 15, 2026 |
| State Street | 5,980,370 | ~$422.5M | 1.9% | August 7, 2026 |
| Fidelity (FMR) | 7,899,928 | ~$412.9M | 678.4% | May 15, 2026 |
| State Street | 5,812,032 | ~$341.8M | — | February 13, 2026 |
| State Street | 5,868,396 | ~$306.7M | 1.0% | May 15, 2026 |
| JP Morgan Chase | 1,862,805 | ~$132.6M | 81.7% | August 12, 2026 |
| Goldman Sachs | 1,943,534 | ~$101.6M | 14.8% | May 15, 2026 |
| Goldman Sachs | 1,692,842 | ~$99.6M | — | March 25, 2026 |
| Millennium Management | 1,123,133 | ~$79.3M | 100.0% | August 14, 2026 |
| Citadel Advisors | 1,050,118 | ~$74.2M | 502.8% | August 14, 2026 |
| Fidelity (FMR) | 1,014,961 | ~$59.7M | — | February 17, 2026 |